Research recommendations coming out of this guidance Can risk of contrast-induced acute kidney injury be stratified by eGFR thresholds? What is the relative effectiveness and cost effectiveness of different oral fluids and different oral fluid regimens, both with and without oral N-acetylcysteine, at preventing contrast-induced acute kidney injury? What validated risk assessment tools could be used to predict the occurrence of contrast-associated acute kidney injury following the administration of intravenous iodine-based contrast media?
What is the relative effectiveness and cost effectiveness of different oral fluids and different oral fluid regimens, both with and without oral N-acetylcysteine, at preventing contrast-induced acute kidney injury?
What validated risk assessment tools could be used to predict the occurrence of contrast-associated acute kidney injury following the administration of intravenous iodine-based contrast media?